Abstract | PURPOSE: METHODS: Patients were randomly assigned to receive parecoxib 80 mg daily i.v. (Group A), lornoxicam 16 mg daily i.v. (Group B) or diclofenac 150 mg daily i.m. (Group C). Rescue analgesia in all groups consisted of pethidine 25 mg i.m. Pain was measured with an analogue scale ( pain intensity score). RESULTS: CONCLUSIONS:
|
Authors | A V Kyriakidis, I Perysinakis, I Alexandris, K Athanasiou, Ch Papadopoulos, I Mpesikos |
Journal | Hernia : the journal of hernias and abdominal wall surgery
(Hernia)
Vol. 15
Issue 1
Pg. 59-64
(Feb 2011)
ISSN: 1248-9204 [Electronic] France |
PMID | 20957399
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Cyclooxygenase 2 Inhibitors
- Isoxazoles
- Piroxicam
- Diclofenac
- parecoxib
- lornoxicam
|
Topics |
- Adult
- Anti-Inflammatory Agents, Non-Steroidal
(adverse effects, therapeutic use)
- Cyclooxygenase 2 Inhibitors
(administration & dosage, adverse effects, therapeutic use)
- Diclofenac
(administration & dosage, adverse effects, therapeutic use)
- Double-Blind Method
- Female
- Hernia, Inguinal
(surgery)
- Humans
- Isoxazoles
(administration & dosage, adverse effects, therapeutic use)
- Male
- Middle Aged
- Pain Measurement
- Pain, Postoperative
(drug therapy, etiology)
- Piroxicam
(administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
- Prospective Studies
- Surgical Procedures, Operative
(adverse effects)
|